Strategic Investment Advisors / MI

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1760540 FARMINGTON HILLS, MI

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,925,234

-$857,506 QoQ

Shares Held

9,090

-6.8% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.89%

of 13F equity value

Holder Rank

#251

of 870 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Strategic Investment Advisors / MI holds $5,122,931 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (96.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	UTHR	UNITED THERAPEUTICS Corp This page	9,090	$4,925,234
2	NBIX	Neurocrine Biosciences Inc	1,173	$197,697

All Filings in UTHR

Export CSV

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,925,234	9,090	-6.8%	Shares	Sole	2026-08-14
2026-03-31	$5,782,740	9,752	+20.5%	Shares	Sole	2026-05-18
2025-12-31	$3,941,852	8,090	-3.8%	Shares	Sole	2026-02-17
2025-09-30	$3,525,556	8,410	-3.9%	Shares	Sole	2025-12-17
2025-06-30	$2,514,025	8,749	+56.2%	Shares	Sole	2025-08-15
2025-03-31	$1,726,620	5,601	-6.4%	Shares	Sole	2025-04-23
2024-12-31	$2,111,041	5,983	+1.6%	Shares	Sole	2025-01-22
2024-09-30	$2,109,964	5,888	+217.6%	Shares	Sole	2024-10-21
2024-06-30	$590,591	1,854	-6.2%	Shares	Sole	2024-07-23
2024-03-31	$454,156	1,977	+6.3%	Shares	Sole	2024-04-23
2023-12-31	$408,775	1,859	-4.7%	Shares	Sole	2024-01-10
2023-09-30	$440,672	1,951	+1.9%	Shares	Sole	2023-10-25
2023-06-30	$422,515	1,914	+11.5%	Shares	Sole	2023-08-14
2023-03-31	$384,315	1,716	+62.7%	Shares	Sole	2023-04-27
2022-12-31	$293,384	1,055	—	Shares	Sole	2023-01-20
No filing history on record for this holder in this stock.